Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREX-ARM: Tranexamic Acid in Breast Reduction
NCT04947514Phase 4Completed
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in postoperative hematoma, sponsored by Montefiore Medical Center. Primary endpoint: Number of Breasts With Development of Hematoma at 30 days. Started Oct 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hematoma
Beyond the preview
Go deeper on NCT04947514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04947514.